Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Address
No.8, Xiyuan Avenue
Chengdu, 611731
China
Phone
86 28 6758 5121
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1400
First IPO Date
September 02, 2020
| Name | Title | Pay | Year Born |
| Daming Zhang | Deputy GM & Director | 0 | 1973 |
| Xiao Qin Bo | Chief Financial Officer, Accounting Supervisor & Director | 0 | 1982 |
| Avinash Ramkisan Mane | Chief Scientist of Formulation Research Department & Core Technician | 0 | 1978 |
| Mingxu Yuan | GM & Director | 0 | 1972 |
| Xingyao Song | Deputy General Manager | 0 | 1977 |
| Zheng Pin Guan | Deputy GM & Core Technician | 0 | 1974 |
| Haibin Guo | Manager of Formulation Research Department & Core Technician | 0 | 1981 |
| Shuyun Li | Board Secretary | 0 | 1985 |
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.